Clinical Trials Directory

Trials / Conditions / Adjunctive Treatment of Major Depressive Disorder

Adjunctive Treatment of Major Depressive Disorder

4 registered clinical trials studyying Adjunctive Treatment of Major Depressive Disorder.

StatusTrialSponsorPhase
CompletedA Study of CLE-100 (Oral Esketamine) in Addition to Standard Antidepressant Drug for Major Depressive Disorder
NCT04103892
Clexio Biosciences Ltd.Phase 2
TerminatedExtension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepr
NCT04000009
ACADIA Pharmaceuticals Inc.Phase 3
CompletedAdjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant T
NCT03968159
ACADIA Pharmaceuticals Inc.Phase 3
CompletedStudy to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
NCT03018340
ACADIA Pharmaceuticals Inc.Phase 2